2026-01-18 - Analysis Report
**Company Details**

* Ticker: CRM
* Company Name: Salesforce Inc.
* Overview: Leading customer relationship management (CRM) and enterprise software provider.

**Return Rate Comparison**

* Cumulative Return of Review Stock: -19.85%
* Cumulative Return of Comparison Stock (S&P 500, VOO): 93.36%
* Divergence (current): -111.10
* Relative Divergence: 0.00%
* Rate vs Rate (VOO): CRM's return rate is significantly lower than the S&P 500.

**Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 21.0% | 29.8% | 17.0% | 1.4 | 130.4B |
| 2017-2019  | 15.0% | 29.8% | -2.0% | 1.4 | 154.8B |
| 2018-2020  | 9.0% | 29.8% | -11.0% | 1.1 | 211.8B |
| 2019-2021  | 33.0% | 21.2% | -10.0% | 1.1 | 241.9B |
| 2020-2022  | -73.0% | 59.8% | -71.0% | 1.2 | 126.2B |
| 2021-2023  | -42.0% | 59.8% | -43.0% | 1.4 | 250.5B |
| 2022-2024  | -37.0% | 52.3% | -56.0% | 1.4 | 318.3B |
| 2023-2025  | 10.0% | 32.1% | -52.0% | 1.2 | 252.2B |

**Recent Stock Price Fluctuations**

* Close: $227.11
* Last-Market: 
  - Price: 227.11
  - Previous Close: 233.53
  - Change: -2.75
* 5-day SMA: $240.13
* 20-day SMA: $256.71
* 60-day SMA: $250.08

**RSI, PPO Index Indicators, and Delta_Previous_Relative_Divergence**

* Market Risk Indicator (MRI): 0.80
* RSI: 19.68
* PPO: -1.75
* Hybrid Signal: Buy (Cash 0%)
Risk Level: Medium (MRI 0.80)
* Recent (20 days) relative divergence change: -6.40 (-): worsening
* 7-day Rank change: -99 (-): rank down
* 7-day Dynamic Expected Return change: -4151.20 (-): worsening
* Expected Return (%): -4980.60%

**Recent News & Significant Events (Extracted from Google News)**

* Reassessing Salesforce (CRM) Valuation After Recent Share Price Weakness And AI Profitability Push - simplywall.st
* Wolfe Research Sees Strong AI Momentum at Salesforce, Inc. (CRM) - Yahoo Finance UK
* Salesforce: Why CRM Stock Is Undervalued At $240? - Forbes
* Salesforce Stock Is Mispriced - Reiterate Buy (NYSE:CRM) - Seeking Alpha
* Salesforce stock has imploded: Is it a bargain or a value trap? - TradingView
* Salesforce.com (CRM) Stock Dips While Market Gains: Key Facts - Yahoo Finance

**Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.64 (~Buy)
- Opinions: 53
- Target Price (avg/high/low): 329.65 / 475.00 / 223.00

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-12-04 | 2.2 | 10.26 B$ |
| 2025-09-04 | 1.97 | 10.24 B$ |
| 2025-05-29 | 1.61 | 9.83 B$ |
| 2024-12-04 | 1.6 | 9.44 B$ |
| 2025-12-04 | 1.6 | 9.44 B$ |

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-10-31 | $10.26B | 78.02% |
| 2025-07-31 | $10.24B | 78.10% |
| 2025-04-30 | $9.83B | 76.96% |
| 2025-01-31 | $9.99B | 77.81% |
| 2024-10-31 | $9.44B | 77.71% |

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-10-31 | $60.02B | 3.48% |
| 2025-07-31 | $61.33B | 3.08% |
| 2025-04-30 | $60.67B | 2.54% |
| 2025-01-31 | $61.17B | 2.79% |
| 2024-10-31 | $58.52B | 2.61% |

**Comprehensive Analysis**

* Salesforce Inc. has struggled with its recent stock performance, with a cumulative return of -19.85% compared to the S&P 500's 93.36%.
* The Alpha, Beta analysis shows that Salesforce has had a mix of positive and negative returns across different periods, with a Beta value above 1 indicating higher volatility.
* The RSI and PPO indicators suggest that the stock is oversold, with a strong potential for a rebound.
* The Market Risk Indicator (MRI) is at 0.80, indicating a medium-risk investment.
* Analyst consensus suggests a buy recommendation with a target price range of 329.65 to 475.00.
* The stock's recent financial performance has been impacted by a decline in revenue, with a decrease in EPS and revenue across various quarters.
* The company's capital and profitability metrics show a slight increase in equity and a decrease in ROE across different quarters.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.